Survival function of TERT promoter mutation in glioma patients.

<p>A: Kaplan-Meier analysis showing the OS of high-grade glioma patients with wild-type (blue line) and mutated (orange line) <i>TERT</i> promoters. The difference in OS was significant between the two groups. B: Kaplan-Meier analysis showing the overall survival (OS) of low-grade glioma (<i>i.e.</i>, astrocytoma) patients with wild-type (blue line) and mutated (orange line) <i>TERT</i> promoters. The difference in OS was significant between the two groups.